PEARLITOL® CR-H Co-processed Mannitol-HPMC

PEARLITOL® CR-H Co-processed Mannitol-HPMC
Product Description

PEARLITOL® CR-H co-processed mannitol HPMC is a direct compression excipient providing functional properties of binder as well as controlled release to your tablet. PEARLITOL® CR-H can be used in both pharmaceutical and nutraceutical oral dosage forms.

Roquette Health & Pharma Solutions

  • Country/Region:
    France
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    5000+
Company types
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Excipients Manufacturer
Nutraceuticals
Specifications

Roquette Health & Pharma Solutions

  • Country/Region:
    France
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    5000+
Company types
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Excipients Manufacturer
Nutraceuticals

More Products from Roquette Health & Pharma Solutions (23)

  • LYCAGEL®  Hydroxypropyl Pea Starch

    Product LYCAGEL® Hydroxypropyl Pea Starch

    LYCAGEL® VS 720 hydroxypropyl pea starch. It offers excellent film-forming properties for the manufacture of veggie soft capsules in both pharmaceutical and nutraceutical applications.
  • METHOCEL™ Cellulose Ethers

    Product METHOCEL™ Cellulose Ethers

    Well-recognized product that can do it allMETHOCELâ„¢ cellulose ethers are water-soluble polymers derived from cellulose. The METHOCELâ„¢ product range encompasses methylcellulose and hydroxypropyl methylcellulose (hypromellose) “ each available in different grades to address a wide range of applications i...
  • PEARLITOL® 200 GT

    Product PEARLITOL® 200 GT

    PEARLITOL® 200 GT, the only Mannitol allowing to produce and to develop drugs faster, thanks to its tableting properties - enhancing patient compliance without compromising drugs stability.
  • PEARLITOL® 200 GT Mannitol

    Product PEARLITOL® 200 GT Mannitol

    PEARLITOL® 200 GT mannitol is a direct compression excipient, specially designed to avoid capping, improve flowability and tabletability. It is a granulated form of mannitol with exceptional physical and chemical stability. It offers high API compatibility and no hygroscopicity. It is also a non-cariogenic...
  • PEARLITOL® CR-H

    Product PEARLITOL® CR-H

    Combining both Roquette Mannitol and HPMC in a synergistic pathway to provide the best flowability in formulating controlled release tablets. Come to our booth to discover more about the benefits of PEARLITOL® CR-H!
  • PEARLITOL® ProTec Co-processed Mannitol-Starch

    Product PEARLITOL® ProTec Co-processed Mannitol-Starch

    PEARLITOL® PROTEC co-processed mannitol starch is designed for the direct compression of moisture sensitive ingredients such as probiotics and vitamins. PEARLITOL® ProTec provides protection from tableting process, including compression and improves stability due to low-water activity. PEARLITOL® ProTec ma...
  • ReadiLYCOAT® hydroxypropyl pea starch

    Product ReadiLYCOAT® hydroxypropyl pea starch

    ReadiLYCOAT® is a range of solutions providing immediate release coating to all kinds of tablets in various oral dosage forms in both pharmaceutical and nutraceutical applications. ReadiLYCOAT® products are mainly composed of hydroxypropyl pea starch. To ensure good film resistance over handling and storag...
  • KLEPTOSE® HP HPB - Hydroxypropyl betacyclodextrin

    Product KLEPTOSE® HP HPB - Hydroxypropyl betacyclodextrin

    Kleptose HP and HPB for pharmaceutical applications: parenteral use, syrup oral suspensions. HPBCD increase water solubility and bioavailability.
  • LYCAGEL® Flex hydroxypropyl pea starch

    Product LYCAGEL® Flex hydroxypropyl pea starch

    LYCAGEL® Flex hydroxypropyl pea starch, carrageenan and disodium phosphate blend is a plant-based, plasticizer-free premix for veggie soft capsules. It provides the Flexibility to select the optimal plasticizer and customize ingredient ratios. LYCAGEL® Flex offers excellent film-forming properties and is u...
  • PEARLITOL® 200 GT Mannitol

    Product PEARLITOL® 200 GT Mannitol

    PEARLITOL® 200 GT mannitol is a direct compression excipient, specially designed to avoid capping, improve flowability and tabletability. It is a granulated form of mannitol with exceptional physical and chemical stability. It offers high API compatibility and no hygroscopicity. It is also a non-cariogenic...
  • PEARLITOL® CR-H Co-processed Mannitol-HPMC

    Product PEARLITOL® CR-H Co-processed Mannitol-HPMC

    PEARLITOL® CR-H co-processed mannitol HPMC is a direct compression excipient providing functional properties of binder as well as controlled release to your tablet. PEARLITOL® CR-H can be used in both pharmaceutical and nutraceutical oral dosage forms.

Roquette Health & Pharma Solutions resources (21)

  • News Roquette to advance drug delivery research with new US Innovation Center

    The new facility will focus on the research of excipients for oral dosage forms, drug delivery systems, nutraceutical APIs and innovative pharma ingredients
  • Brochure BROCHURE - Roquette Pharmaceuticals and Nutraceuticals

    Discover the wide range of products by Roquette in Pharmaceuticals and Neutraceuticals
  • Sponsored Content IFF Pharma Solutions: Paving the Way for Superior Suspensions

    Shawn Branning, Global Strategic Marketing Manager at IFF – Pharma Solutions

  • Industry Webinar Innovation – Addressing Patient Compliance and Enhancing Consumer Experience

    It’s a hard pill to swallow, but medication adherence is a crucial issue today. For oral formulations in pharma and nutraceuticals, taste, appearance, and aroma directly impact patient compliance and consumer experience.
    Choosing the right excipients to provide optimum performance while continuing to appeal to patients and consumers alike is critical in bringing finished formulations to market.
  • Industry Webinar Latest Trends in Consumer Health

    Worldwide, people are increasingly health-conscious and aware of the impact of individual lifestyle choices on their health and the health of others. In the latest years, consumers seek more and more transparency from companies through their brand, product manufacturing, and actions that promote well-being for the world around them. While also looking for more affordable, accessible, and personalized product experiences. This session explores the latest news and insight on consumer health, including how pharma engages patients in education and decision-making.
  • Video Polysorbates versus Hydroxypropyl Beta-Cyclodextrin (HPBCD) Stability Comparative Study and their Monoclonal Antibody Stability Benefits

    Polysorbates are intensively used in biologics formulation as stabilizer due to their propensity to inhibit aggregation at interfaces but possess low intrinsic stability. In this study, the chemical stability of KLEPTOSE® HPBCDs are compared with polysorbates under various stress conditions.

    When subjected to heat stress and other chemical stressors – autoclave, light and oxidative stresses – HPBCD remains almost stable while polysorbates show more severe degradation. Further, profiling characterization and degradation analysis reveal that HPBCD chemical structure remains intact while polysorbates undergo significant hydrolytic degradation and oxidation.

    Lastly, the physicochemical stability of monoclonal antibody in formulations have been investigated using adalimumab as a model protein. When subjected to light stress, HPBCD-containing formulations show significant decreases in protein aggregation, as well as superior monomer and total protein recovery compared to polysorbate-containing formulations. HPBCD also reduces both agitation and thermal stress-induced protein aggregation and prevents sub-visible particle formation compared to polysorbates.


    Click here to register

  • Industry Podcast Podcast: Ensuring Reliable Quality in Excipient Products

    In this podcast episode, Kieran O'Dwyer, Global Quality Leader at DuPont Nutrition & Health, meets with our editor Gareth Carpenter to discuss excipients products and ensuring a consistent level of quality. Kieran is a speaker at the CPHI Festival of Pharma. This podcast was originally aired as part of the CPHI Festival of Pharma.
  • Video Paediatric Drug Delivery: Challenges and Solutions

    This session was originally broadcast as part of the CPHI Worldwide 2021 digital content programme. Developing medicines for the pediatric population can be challenging, requiring different formulations, dosage forms and strengths, or different routes of administration. This session explores the hurdles and emerging opportunities to develop an optimal drug delivery addressing issues such as adherence and acceptability in the pediatric population. Critical development & administration challenges for paediatric medicines New technologies for developing and delivering optimal dosage forms Advantages and Disadvantages of Standards and Novel Strategies for Drug Administration in Paediatrics Emerging Opportunities
  • Brochure AVICEL®️ MCC & Related Co-processed Products

    For nearly 60 years, Avicel®️ has exceeded the performance of common pill binders by pushing the boundaries of science in tablet binding, leading to a premier product supported by true experts in the field. Find out more.
  • Brochure Meet IFF Pharma Solutions

    Meet the makers of Avicel®️ and METHOCEL™️. Delivering expertise, innovation, and a passion to solve for drug delivery. Find out more
  • Brochure Enabling Technologies in Suspensions

    Our experts can help you design an optimal liquid or semi-solid application using our broad portfolio of specialized excipients and deep expertise in suspensions. Find out more.
  • Brochure IFF Pharma Solutions Product Portfolio

    With decades of vital experience in the pharma industry, we have a proven track record of working with customers around the globe to differentiate drug formulations and solve the toughest challenges with our robust excipients portfolio. Find out more.
  • Video The Landscape of Affordable Healthcare

    The changing landscape for coverage of healthcare services and medical products is creating new challenges in making sure patients have affordable access to care, and that those financing these opportunities can sustain these investments. How we can develop sustainable models for covering the cost of new innovations and modernize our payment models; to make sure that patients have access to the medical care they need without bankrupting our healthcare system. What are the new models for healthcare delivery that we’ll need to embrace? CPHI is delighted to welcome, Dr. Scott Gottlieb, who served as the 23rd Commissioner of Food and Drugs, for our regulatory keynote. Aired as part of the CPHI Festival of pharma
  • Video Roquette Pharma Solutions: Innovation Hub

    Learn more about Roquette´s new online technical search platform, Innovation Hub, a virtual destination for formulators to get what they need at the click of a button. As a part of Innovation Hub, please also meet Rosa, a new virtual technical assistant which help users to search formulation, read our research on direct compression, and directly get in touch with our Technical Support team. For more information and to try Innovation Hub for yourself, please visit: www.roquette.com/innovation-hub